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Background: Results of recent national surveys have shown the high prevalence of exposure to bisphenol A (BPA)
and triclosan (TCS) among the general population; however biomonitoring data for pregnant women and infants
are limited.
Methods:Women (n= 80) were recruited from early prenatal clinics and asked to collect urine samples multiple
times during pregnancy and once 2–3 months post-partum. Samples of infant urine and meconium as well as
breast milk and infant formula were also collected. Biospecimens were analyzed by GC–MS/MS for BPA, TCS and
triclocarban (TCC).
Results: Triclosan was detected in over 80% of the maternal urines (geometric mean (GM): 21.61 μg/L), 60% of the
infant urines (GM: 2.8 μg/L), 46% of the breastmilk and 80% of themeconium samples. Triclocarbanwas rarely de-
tected in any of the biospecimens.Median total BPA concentrationswere 1.21 and 0.24 μg/L inmaternal and infant
urines, respectively. Free BPA was detected in only 11% of infant urine samples. The meconium of female infants
had signiﬁcantly higher concentrations of total BPA and TCS than those of males, while no differences were
observed in infant urine concentrations by sex.
Conclusions:We foundwidespread exposure among pregnant women and infants to environmental phenols, with
large inter-individual variability in exposure to triclosan. These data will contribute to the risk assessment of these
chemicals, especially in susceptible sub-populations.
Crown Copyright © 2014 Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).on, Healthy Environments and
Dr., AL 0801A, Ottawa, ON K1A
le).
r B.V. This is an open access article u1. Introduction
Environmental phenols such as bisphenol A (BPA), triclosan (TCS)
and triclocarban (TCC) are non-persistent ubiquitous chemicals that
are primarily excreted in urine. BPA and TCS are commonly detected
in urine samples from national surveys in Canada and the Unitednder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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CDC, 2013; Ye et al., 2011a).
Triclosan is used to preserve materials such as textiles, leather,
paper, plastic and rubber and as an anti-bacterial and anti-fungal
agent in a number of cosmetics and personal care consumer products
including non-prescription drugs and natural health products (Health
Canada and Environment Canada, 2012). The US Department of Health
and Human Services lists a number of household products in their
database which contain TCS or TCC (http://householdproducts.nlm.
nih.gov/index.htm, accessed February 19, 2014). TCS can be found in
antibacterial hand soaps, dishwashing liquid, toothpaste, shaving gel,
antiperspirant, deodorant, face and body wash, hand lotion, lipcolor,
and antibacterial dog shampoo. Self-reported use of personal care
products in adolescents has been reported to be a signiﬁcant determinant
of urinary TCS concentrations (Den Hond et al., 2013).
TCC is also used in a number of consumer products as an antibacte-
rial agent in the US; however, published data to date indicates that the
number of products containing TCC is far fewer than those containing
TCS. Unlike in the US, no drug products are marketed in Canada with
triclocarban as an active medicinal ingredient nor is it an ingredient in
any licensed natural health product (http://webprod3.hc-sc.gc.ca/
lnhpd-bdpsnh/start-debuter.do?lang=eng; http://webprod5.hc-sc.gc.
ca/dpd-bdpp/index-eng.jsp, accessed August 20, 2013).
BPA is an industrial chemical that has been used in the manufacture
of polycarbonate plastics and in hardeners, paperboard packaging,
adhesives, custom color powder coatings and as a curing agent for
resurfacing concrete, and is also found in epoxy resins used to line
metal food and beverage cans (Environment Canada and Health
Canada, 2008). Approximately two-thirds of the intake of BPA in adults
is estimated to come from dietary sources, with the balance from other
routes (Christensen et al., 2013).
Only two epidemiologic studies have explored potential health
effects of prenatal exposure to TCS and reported no signiﬁcant impact
on birth weight, length or head circumference (Wolff et al., 2008;
Philippat et al., 2012); however one of these studies did report that
male infants were signiﬁcantly shorter when prenatally exposed to
higher levels of TCS (Wolff et al., 2008).
Epidemiologic studies on the effects of prenatal exposure to BPA on
pregnancy outcomes are limited, with often no signiﬁcant effects
observed or in the case of total BPA and fetal growth, conﬂicting results
(Lee et al., 2014; Chen et al., 2013; Tang et al., 2013; Snijder et al., 2013;
Robledo et al., 2013; Philippat et al., 2012; Cantonwine et al., 2010;
Wolff et al., 2008). Similarly some studies have reported no observed
effects of prenatal BPA exposure on child behavior (Miodovnik et al.,
2011; Yolton et al., 2011) while others found signiﬁcant effects
(Harley et al., 2013a; Perera et al., 2012; Braun et al., 2011a) with
support from the toxicological literature for sexually dimorphic pheno-
types (Kundakovic et al., 2013; McCaffery et al., 2013; Wolstenholme
et al., 2011).
Given the potential for endocrine disruption associated with
BPA (Meeker, 2012), triclosan (evidence in rodents with uncertain
implications for humans) (Allmyr et al., 2009; Cullinan et al., 2012;
Koeppe et al., 2013) and triclocarban (Witorsch and Thomas, 2010),
and the paucity of data on early life exposure to these chemicals,
a prospective pregnancy study was conducted. As the free phenol
is presumed to be more biologically active, we measured both total
(free plus conjugated) and free BPA in infant urine, meconium and
breast milk.
2. Materials and methods
2.1. Study population
Women in early pregnancy (b20 weeks gestation)were approached
at prenatal clinics in Ottawa (Ontario, Canada) betweenDecember 2009
and December 2010 and invited to participate in the Plastics andPersonal-care Products use in Pregnancy (P4) Study. A poster and
pamphlets were also placed in the obstetrical and ultrasound clinics
of The Ottawa Hospital and physician ofﬁces. Eligibility criteria included
ability to consent and to communicate in English or French, age 18 years
or older and planning on delivering within the City of Ottawa.
Women with major medical conditions such as renal disease, epilepsy,
heart disease and cancer or with known fetal abnormalities or major
malformations were excluded from the study. In addition, women
who were already participating in 2 or more research studies were
disqualiﬁed. The study was approved by human studies ethics commit-
tees at Health Canada and the Ottawa Hospital and all participants
signed an informed consent form.
2.2. Data and biospecimen collection
2.2.1. Maternal urine collection
Women who consented to participate were asked to collect every
urine void in separate containers over a 24-hour period during early
pregnancy (between 6 and 19 weeks), as well as a spot urine void
during the 2nd (24–28 weeks) and 3rd (32–36 weeks) trimesters and
2–3 months post-partum (Table 1). During early pregnancy, women
were asked to collect and record the dates and times of all urine voids
over a 24-hour period on a week-day (T1a) and/or a week-end day
(T1b). Women were provided with pre-screened urine cups (polypro-
pylene) and a cooler bag with ice packs. To avoid degradation of the
target chemicals, the urine was kept cool (4 °C) during the collection
period, mixed well and aliquoted within 36 h of collection and then
stored frozen at−80 °C. A research assistant visited the participants'
homes to retrieve the urine samples that were collected over the
24-hour period. The spot samples were collected during regularly
scheduled clinic visits or at home and women were asked to provide
information on the time of the void and the time since last void.
2.2.2. Infant urine collection
Infant urine was collected twice in the early post-natal period using
pre-screened newborn urine-bags (U-bags) (Hollister Inc. Libertyville,
IL; and Mabis Healthcare, Waukegan, IL) (Table 1). The ﬁrst infant
urine sample was collected either at the hospital, if possible, or at
home up to one month after birth (T4).
Prior to collecting infant urine, the genital area was cleansed using
only warm water and a washcloth, allowed to air dry and then a U-
bagwas attached.When at least 5mL of urinewas collected, the sample
was transferred from the U-bag into sterile 30mL Nalgene® containers.
The date and time the bag was removed were noted and the urine
refrigerated. Within 24 h of collection, the urine was aliquoted and
frozen at −80 °C. The maximum length of time the U-bag was left
attached to the infant was 4 h. Infant urine was also collected 2–
3 months post-partum (T5) during a home visit.
2.2.3. Meconium collection
Pre-screened Mère Hélène® bioliners (Mère Hélène, Quebec
Canada) were inserted into the diapers. After the meconium was
passed, a wooden spatula was used to transfer the meconium to a
50 mL Sarstedt tube and then refrigerated. The sample was collected
on one or more occasions within the ﬁrst two days after delivery until
approximately 10 g was collected. A note was to be made if the diaper
was wet with urine and of any lotions, powders, wipes or creams that
had been applied to the baby's bottom. The samples were pooled and
frozen within 72 h of collection at−20 °C.
2.2.4. Breast milk and/or infant formula
Two to three months post-partum, a sample of breast milk (mini-
mum 20–30 mL) was collected in a 150 mL glass jar. The women were
provided with a Medela® (Medela International, Zug, Switzerland)
manual breast pump prior to delivery. Alternatively, women could
choose to hand express directly into the glass container. Immediately
Table 1
Data and biospecimen collection by visit for the P4 Study.
Pregnancy visits Post delivery visits
Early pregnancy (6–b20 weeks) 2nd trimester (24–28 weeks) 3rd trimester (32–36 weeks) b1 month 2–3 months
T1a (weekday) T1b (weekend) T2 T3 T4 T5
Questionnaire ● ● ● ●
Maternal urine ● (Serial over 24 h) ● (Serial over 24 h) ● ● ●
Meconium ●
Infant urine ● (n = 45) ● (n = 55)
Breast milk ●
Infant formula ●
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pump bottle to the glass jar. Mothers were asked not to use any creams
or cleansers on her breast, prior to pumping. Women who were not
breastfeeding or who were supplementing with formula were asked
to document the brand of formula and provide a minimum of 20–
30 mL in the glass jar provided. The breast milk and infant formula
were stored in a cooler bag with freezer packs or refrigerated until
delivery to hospital. At the lab, the samples were aliquoted into 30 mL
Nalgene® containers and frozen at−20 °C.
2.2.5. Questionnaires and exposure diary
Upon recruitment, womenwere asked to complete a short question-
naire and given an exposure diary to complete. The questionnaire col-
lected demographic, socio-economic, obstetrical history, smoking
history and current pregnancy information, as well as information on
their occupation. Short questionnaires were also completed during
pregnancy to update information on the pregnancy, as well as postna-
tally to collect data on infant feeding and care practices. Additional
data on the pregnancy and the birth were abstracted from medical
charts.
2.3. Screening of collection materials and ﬁeld blanks
All collectionmaterials provided to participants and used for storage
were pre-screened for potential contamination. Diaper bioliners were
screened with acetonitrile extraction after being soaked overnight.
Detectable levels of free BPA were observed (0.007 μg/g liner). No TCS
or TCC was detected in the bioliners and no BPA, TCS or TCC was
measured in any of the urine collection or storage materials. While no
BPA or TCC was detected in the breast pump, 0.62 μg/L of TCS was
detected (LOD= 0.58 μg/L).
For each collection period and participant, a ﬁeld blankwas included
to assess potential risks of contamination at the collection premises.
These would not only consider risks from the sampling collection
materials (tubes, transfer vials, etc.) but the collection sites' environ-
ment as well. Steril.O reagent grade deionized distilled water was
used as the sampling media. Field blanks were handled and analyzed
at the same time and similarly to the biospecimens. To create ﬁeld
blanks for the infant urines, 5 ml of the deionized water was added to
sample U-bags, jostled to simulate infant movement while wearing
the bag and left to sit at room temperature for at least 30 min and
then transferred into sterile 30 mL Nalgene® containers.
2.4. Laboratory chemical analysis
To account for varying urine dilutions, speciﬁc gravitywasmeasured
using an Atago UG-α digital urine refractometer (Atago U.S.A. Inc.,
Bellevue, WA) on urine samples that had undergone a freeze–thaw
cycle.
Biological samples and ﬁeld blanks were shipped in dry ice to the
laboratory in batches where they were kept at−20 °C until they were
placed at 4 °C the day before analysis to be thawed.For all methods described below, the samples were ﬁrst thawed,
mixed thoroughly and then subsamples were enriched with their
corresponding isotopically-labeled carbon 13 analogs (BPA-13C12,
TCS-13C12 and TCC-13C13) before treatment.
2.4.1. Measurement of total BPA and TCS, TCC and free BPA in urine
For urine measurements, the analytical methodology and technical
information have previously been described (Provencher et al., 2014);
for TCC, further details are provided in the Supplemental material. In
brief,when the total forms of BPA, TCS andTCCweremeasured, samples
were, prior to treatment, submitted to enzymatic hydrolysis with β-
glucuronidase in acetate buffer at pH 5 for 16 h at 37 °C. 100 μL of
urine samplewere derivatized at 70 °Cwithpentaﬂuorobenzyl bromide
(PFB-Br) and potassium carbonate for 2 h. Total TCC was separately an-
alyzed using sulfuric acid hydrolysis at 80 °C and PFB-Br derivatization
catalyzed with cesium carbonate for 1 h at 80 °C. BPA, TCS and TCC
pentaﬂuorobenzyl (PFB) derivatives were extracted with a mixture of
dichloromethane:hexane (20:80, v:v) concentrated and analyzed by
GC–MS/MS.
2.4.2. Measurement of free and total BPA, TCS and TCC inmeconium, breast
milk and infant formula
The samples of meconium (100 mg), breast milk (100 μL) or infant
formula (100 μL) were mixed with acetate buffer. For the meconium,
the mix of samples was performed by homogenization to assure
their homogeneity. When the total forms of BPA, TCS and TCC were
measured, the samples were incubated with β-glucuronidase for 3 h
at 37 °C. After protein precipitation with acetonitrile and addition of
NaCl, phenols were liquid–liquid extracted using chlorobutane. The
organic phase was evaporated and compounds derivatized at 80 °C in
the presence of PFB-Br and cesium carbonate for 1 h. After cooling,
water and a solution of dichloromethane:hexane (8:92, v:v) was
added to the samples for extraction of the PFB derivatives of BPA, TCS
and TCC. Extracts were dried under vacuum and reconstituted with a
solution of dichloromethane:hexane (20:80, v:v) and analyzed by GC–
MS/MS.
2.4.3. Gas chromatographic analysis of BPA, TCS and TCC
All extracts were analyzed using a GC–MS/MS (Agilent 6890 gas
chromatograph coupled with a Waters Quattro Micro GC tandem
mass spectrometer) equipped with a HP-5MS 30 m, 0.25 mm internal
diameter, 0.25 μm ﬁlm thickness analytical capillary column (Agilent
Technologies, Mississauga, ON, Canada). The measurement of ions
generated was performed in multiple reaction monitoring (MRM)
mode with negative ion chemical ionization (NICI) using methane as
the reagent gas.
2.4.4. Method performance
The methods were fully validated for each matrix using ISO 17025
guidelines. Method limits of detection based on repeatability were
evaluated as three times the standard deviation of ten replicate analyses
of the spiked matrix at levels around two times the LOQ. Limits of
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mental Material Table S1.
As described in Provencher et al. (2014), the ID-GC–MS-MS method
for total BPA and TCS in urine produces results in excellent agreement
with those obtained by ID-LC–MS/MS. The authors only noted a small
over-estimation of BPA concentrations by the LC–MS-MS method.
The GC–MS/MS method accuracy for total BPA in urine has also been
extensively evaluated with success over the last several years by partic-
ipating in the German external quality assessment scheme.
2.4.5. Laboratory contamination
Procedural reagent blankswere systematically prepared in duplicate
in each analytical sequence of 20 samples. TCS and TCC blank levels
were always undetected for all types of samples treated. However,
BPA blanks were systematically positive with BPA originating mainly
from cumulative slight contamination of reagents that remained
after extensive elimination of all other potential procedural external
contamination. These positive BPA values of reagent blanks were close
to the LOD and were highly reproducible (inter- and intra-batches)
and were subtracted from the back-calculated results of unknown
samples.
2.5. Statistical analysis
Raw data for results less than the limits of detection were available
and used in calculating percentiles and geometric means (GM) and
95% conﬁdence intervals of phenols in the various matrices. Since
normality assumptions were not satisﬁed, BPA and TCS concentrations
were log transformed and we imputed 0.0001 for values of 0. Both
unadjusted and speciﬁc gravity adjusted results were calculated, using
the following formula for the speciﬁc gravity adjustments:
Pc ¼ Pi SGm–1ð Þ= SGi–1ð Þ½ 
where Pc is the SG-adjusted metabolite concentration (ng per mL), Pi is
the observedmetabolite concentration, and SGi is the speciﬁc gravity of
the urine sample and SGm is the median SG for the maternal or infant
cohort.
To compare with other studies, both fresh weight (TCS concentra-
tion/1.03 {density of milk}) and lipid-adjusted (fresh weight TCS/%
lipids/100) TCS concentrations in breast milk were calculated.
Spearman correlations were calculated to examine associations
between maternal and infant matrix concentrations. For calculating
correlations of T1a and T1b urinary concentrationswith other variables,
bootstrappingwas used to calculate themedian of all correlations and a
permutation test was done to determine the statistical signiﬁcance of
the correlation (p-values b 0.05 were deemed statistically signiﬁcant).
The covariates selected a priori as potential predictors of maternal
urinary BPA and TCS concentrations included: maternal age, born
in Canada or elsewhere, body mass index (BMI), parity, season of
collection, total volume, smoking status, time since last void and time
of day of urine collection, household income, education, and occupation.
Bivariate modeling was performed to examine associations between
each covariate and the log transformedmaternal urinary concentrations
of BPA and TCS across all visit samples. Speciﬁc gravity was included in
each model as a covariate. Given that the data involved repeated
measurements from the same individual, a linear mixed effects
model with random subject effect was used to account for potential
correlations of measurements within an individual. SG-adjusted
geometric means of maternal urinary chemical concentrations (BPA,
TCS) were calculated for all maternal urines by categories of the
covariates. Similarly, predictors of infant urinary and breast milk
concentrations were evaluated using linear modeling.
Statistical analysis was performed using SAS (Statistical Analysis
System) Enterprise Guide 4.2.3. Results
3.1. Study population
Given the burden on participants, it was difﬁcult to recruit women
representative of the study area,with only 11% of those eligible agreeing
to participate. The average age of the 80 participants was 32.4 years,
with 89% having a college or university degree, 46% having their ﬁrst
pregnancy and about 28% being overweight or obese (See Supplemental
Table S2). Smoking prevalence in the study population was very low.
Speciﬁcally, two participants reported smoking occasionally at T1, one
reported smoking at T2 and none at T3 (data not shown). As a result
womenwere categorized into ever (including the2 occasional smokers)
(68%) versus never (32%) smokers.
3.2. Field blanks
Field blanks for total and free BPA, triclosan and triclocarban in
maternal and infant urines and breast milk were generally at or below
the limit of detection. Four of the 67 maternal urine ﬁeld blanks (6%)
had total BPA results exceeding the limit of detection, with a maximum
reading of 0.40 μg/L (LOD was 0.2 μg/L). Three percent (2 of 63) of the
breast milk ﬁeld blanks exceeded the limit of detection of 0.3 μg/L
total BPAwith the maximum value of 0.32 μg/L. As no consistent results
were observed for the ﬁeld blanks and those that were positive were
close to the LOD, no adjustments were made.
3.3. Descriptive statistics
The SG-adjusted median maternal and infant urinary TCS concen-
trations were 23.3 and 6.1 μg/L, respectively. Triclosan was detected in
84% of maternal urines, 61% of infant urines, 22% of infant formulas,
46% of breast milk samples, and 81% of the meconium samples; how-
ever the geometric means for the infant formula and breast milk were
less than the limit of detection (Table 2). Triclocarban was rarely
detected in any of the biospecimens with none measured in breast
milk or infant formula and less than 4% in urine or meconium (data
not shown).
Median SG-adjusted maternal and infant urinary concentrations of
total BPA were 1.26 and 0.21 μg/L, respectively; however, the infant
urine median was near the LOD. Most (92%) of the maternal urines,
40% of the infant urines, 54% of themeconium, 30% of the infant formula
and only 5% of the breast milk samples had detectable concentrations of
total BPA. Only 11% of the infant urines but 48% of the meconium
samples had detectable concentrations of free BPA; however, the latter
ﬁgure is questionable as the liners may have been a source of free BPA.
Allwomenhad at least one urine samplewith detectable concentrations
of total BPA, 60% of the infants had at least one urine sample with
detectable concentrations of total BPA and 13% with detectable con-
centrations of free BPA (data not shown).
The geometric mean of the ratios of free to total BPA in infant
urine was similar for both the T4 and T5 urine samples (0.4 and 0.5,
respectively) with the 50th percentile of 0.12 and 0.17, respectively;
however, the geometric mean ratio of free to total BPA in meconium
was 0.8 (data not shown).
3.4. Predictors of matrix concentrations
3.4.1. TCS
Maternal urinary triclosan concentrations did not differ signiﬁcantly
whether the sample was collected during or post-pregnancy (Supple-
mental Fig. S1). Infant urinary triclosan did not differ signiﬁcantly by
sex; however, females had signiﬁcantly higher geometricmeanmeconi-
um concentrations (3.25 ng/g) than males (0.97 ng/g). Meconium
concentrations of triclosan were signiﬁcantly correlated with both
maternal (especially during the 2nd and 3rd trimesters; r = 0.8) and
Table 2
Geometricmean (GM) and selected percentiles of triclosan and bisphenol A concentrations in all maternal urines, infant urines, infant formula, breast milk, andmeconium for a Canadian
population: data from P4 Study 2009–2011.
Matrix GM (95% CI) 10th 50th 90th 95th Max No. % b LOD
Triclosan
Maternal urine (μg/L) 21.6 (18.17–25.71) bLOD 25.3 (21.2–29.6) 523.2 (471.3–591.7) 833.4 (740.7–918.1) 3229.3 1247 16.4
SG-adjusted 22.9 (19.2–27.2) bLOD 23.3 (20.7–26.8) 526.4 (466.2–576.2) 774.9 (673.6–880.8) 2452.4 1247 13.2
Infant urine (μg/L) 2.8 (1.6–4.9) bLOD 3.9 (3.1–5.1) 21.5 (14.9–61.0) 52.0 (22.7–100.0) 99.9 100 39.0
SG-adjusted 2.5 (1.5–4.4) bLOD 6.1 (4.8–8.5) 35.3 (16.9–53.4) 53.4 (35.2–229.8) 229.8 98 24.0
Infant formula (μg/L) b LOD bLOD bLOD 1.0 (0.9–3.8) 1.1 (1.0–3.8) 3.8 23 78.3
Breast milk (μg/L) 0.05 (0.01–0.2) bLOD bLOD 3.6 (1.7–16.0) 8.8 (3.3–75.4) 75.4 56 53.6
Fresh weight (ng/g) 0.05 bLOD 0.45 3.52 8.51 73.18 56 56.3%
Lipid (ng/g lipids) 2.5 bLOD 19.2 95.2 156.0 2287.0 52 56.3%
Meconium (ng/g) 2.24 (0.97–5.2) bLOD 3.2 (1.3–12.2) 36.5 (24.6–77.0) 68.8 (30.9–77.0) 77.0 52 19.2
Total BPA
Maternal urine (μg/L) 1.1 (1.0–1.2) 0.3 1.2 4.0 6.4 297.8 1238 8
SG-adjusted 1.2 (1.1–1.3) 0.5 1.3 3.7 5.6 191.4 1238 4
Infant urine (μg/L) bLOD bLOD 0.2 2.3 3.4 9.4 100 60
SG-adjusted bLOD bLOD 0.2 1.4 3.4 12.3 100 61
Infant formula (μg/L) bLOD bLOD bLOD 1.2 1.5 9.0 23 70
Breast milk (μg/L) bLOD bLOD bLOD bLOD 0.4 1.9 56 95
Meconium (ng/g) 0.52 (0.39–0.69) bLOD 0.60 1.65 2.65 3.93 54 46
Free BPA
Infant urine (μg/L) bLOD bLOD bLOD 0.2 0.6 9.2 100 89
SG-adjusted bLOD bLOD bLOD 0.2 0.4 12.0 100 89
Breast milk (μg/L) bLOD bLOD bLOD bLOD bLOD 1.6 56 96
Infant formula (μg/L) bLOD bLOD bLOD 1.0 1.6 9.0 23 74
LOD: limit of detection.
LODs in urine: free BPA: 0.1; total BPA: 0.2; triclosan: 3.0 μg/L. LODs in breast milk/formula: free BPA: 0.30; total BPA: 0.30; triclosan: 0.58 μg/L.
LODs in meconium: total BPA: 0.48; triclosan: 0.49 ng/g.
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correlations were also observed between triclosan concentrations in
breast milk and maternal urine collected at visits T2 (r = 0.5), T3
(r = 0.4) and T5 (r = 0.6) and infant urine collected at the same time
as the breastmilk (r= 0.4). However, the geometricmean TCS in infant
urine at T5 did not vary by whether or not the infant was exclusively
breastfed, nor for breast milk, by how the sample was collected
(Table 3).
Signiﬁcantly lower maternal urinary concentrations of TCS were
found in samples collected between 4 p.m. and midnight, less than
90 min from the previous void, and on a weekday (Table 4). TCS
concentrations were highest in samples collected in the autumn and
in primiparous women.
3.4.2. BPA
No signiﬁcant differences in maternal urinary concentrations of BPA
were observed by visit (Supplemental Fig. S2). Infant urinary concentra-
tions of total and free BPA, adjusted for speciﬁc gravity did not differTable 3
Speciﬁc gravity-adjusted infant urinary and breast milk concentrations of phenols by infant fee
Infant urine (T5) N Total BPA
p-Valuea GM (95% CI)
Infant feeding
Exclusively breast fed 33 0.04 0.09 (0.03, 0.25)
Exclusively formula 6 1.04 (0.20, 5.36)
Combination of the two 14 0.35 (0.18, 0.69)
Breast milkb
Collected by:
Hand 16
Mechanical pump 20
Electrical pump 17
a p-Value for overall group effect using ANOVA.
b BPA and free BPA concentrations not shown because ≥95% below the detection limit.signiﬁcantly by visit or by sex (data not shown); however, females
had signiﬁcantly higher geometric mean concentrations (p b 0.05) of
both total (0.75 ng/g) and free BPA (0.45 ng/g) in their meconium
than males (0.31 and 0.14 ng/g, respectively). No signiﬁcant correla-
tions were observed between maternal or infant urine concentrations
of total BPA and meconium or breast milk (data not shown). A sign-
iﬁcant correlation was observed between free BPA in infant urine
and breast milk (r = 0.36), albeit based on small numbers and low
detection frequency.
Infants who were fed exclusively with formula had signiﬁcantly
higher total BPA in their urine, compared to those whowere exclusively
breast fed or by a combination of both formula and breast feeding
(Table 3).
Some factors describing when the urine was collected were sign-
iﬁcant predictors of elevated maternal total BPA urinary concentration,
speciﬁcally time of day (between 4 p.m. and midnight) and on week-
ends (Table 4). Urine collected within 90 min of the previous void had
signiﬁcantly lower concentrations of total BPA. While the sample sizeding and breast milk collection practices.
Free BPA Total TCS
p-Valuea GM (95% CI) p-Valuea GM (95% CI)
0.88 0.01 (0.00, 0.05) 0.75 2.70 (1.13, 6.44)
0.01 (0.00, 4.07) 6.21 (1.49, 25.85)
0.02 (0.00, 0.16) 2.18 (0.23, 21.00)
0.39 0.02 (0.00, 0.45)
0.05 (0.00, 0.45)
0.23 (0.03, 1.94)
Table 4
Speciﬁc gravity (SG) adjusted geometric means (GM) and bivariate predictors of maternal urinary BPA and TCS with speciﬁc gravity included as a covariate in the ﬁxed effects regression
model (n = up to 1269 urines from up to 80 women).
Characteristic N (# samples) BPA (μg/L) TCS (μg/L)
p-Valuea SG-adjusted GM p-Valuea SG-adjusted GM
Time of day
00:00–07:59 282 b0.0001 1.18 0.02 29.47
08:00–11:59 302 b0.0001 1.05 0.01 28.55
12:00–15:59 235 0.01 1.31 0.04 28.11
16:00–23:59 412 Referent 1.63 Referent 18.37
Time since last void (min.)
0–89 284 0.02 1.16 0.05 15.60
90–149 331 0.58 1.27 0.71 30.70
150–209 214 0.47 1.35 0.61 30.74
≥210 315 Referent 1.45 Referent 29.53
Total volume (mL)
b 40 130 0.43 1.30 0.99 31.91
40–64 362 0.33 1.18 0.72 28.11
65–89 296 0.72 1.37 0.28 21.66
≥90 455 Referent 1.35 Referent 23.09
Collection Day
Weekday 686 Referent 1.20 Referent 21.28
Weekend 574 0.02 1.42 0.008 29.17
Season of collection
Spring 299 0.823 1.29 0.06 21.08
Summer 297 0.31 1.21 0.05 23.86
Autumn 387 0.06 1.41 0.001 33.22
Winter 277 Referent 1.24 Referent 19.42
Pre-pregnancy BMI
Underweight or normal 777 Referent 1.29 Referent 18.75
Overweight or obese 364 0.25 1.52 0.35 30.11
Parity
0 546 0.35 1.55 0.04 41.11
1 569 0.57 1.11 0.29 21.19
≥2 145 Referent 1.19 Referent 6.35
Collection period
6–19 weeks (weekday) 512 0.44 1.22 0.81 21.68
6–19 weeks (weekend day) 544 0.09 1.41 0.21 28.81
24–28 weeks 70 0.15 1.42 0.94 25.11
32–36 weeks 71 0.86 1.04 0.64 20.45
2–3 months post-partum 63 Referent 1.13 Referent 20.63
Born in Canada
No 237 Referent 0.95 Referent 18.01
Yes 1023 0.02 1.39 0.89 26.37
Maternal age (years)
b30 218 Referent 1.32 Referent 18.53
30–35 588 0.72 1.32 0.66 26.77
N35 436 0.79 1.27 0.99 21.93
Household income
b$100,000 468 0.42 1.21 0.12 14.63
≥$100,000 732 Referent 1.36 Referent 33.63
Education
Less than college diploma 114 0.01 1.83 0.89 15.78
College diploma 198 0.63 1.20 0.27 39.73
University degree 590 Referent 1.11 Referent 22.02
MSc or PhD 358 0.03 1.55 0.64 25.87
Smoking status
Never 825 Referent 1.22 0.29 29.65
Ever 402 0.37 1.47 Referent 13.33
Marital status
Married 1029 0.04 1.22 0.06 29.58
Single or with partner 231 Referent 1.68 Referent 66.92
Employment status
Health care worker 254 0.07 1.27 0.10 37.45
Ofﬁce or government worker 472 0.02 1.36 0.11 30.96
Unemployed 198 Referent 0.92 Referent 5.37
Other jobs (teachers, sales, etc.) 336 0.006 1.50 0.10 31.58
a p-Values calculated on log-transformed SG-adjusted concentrations using a linear mixed effects model with random subject effect to account for potential correlations of measure-
ments within an individual.
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observed by maternal age, household income, parity or pre-pregnancy
BMI categories. Unemployed women had signiﬁcantly lower exposure
to BPA while women born in Canada had signiﬁcantly higher urinary
BPA.4. Discussion
4.1. TCS and TCC
The geometric mean and median urinary triclosan concentrations of
all maternal samples (n = 1247) were 21.6 and 25.3 μg/L, respectively,
which are higher than those reported in studies of pregnant women in
California (California, 2013), New York (Wolff et al., 2008; Philippat
et al., 2013), Spain (Casas et al., 2011), Norway (Bertelsen et al., 2014),
Denmark (Tefre de Renzy-Martin et al., 2014; Frederiksen et al., 2014),
US NHANES (Woodruff et al., 2011), US pilot sites for the National
Children's Study (NCS) (Mortensen et al., 2014) and Canada (Arbuckle
et al., 2014a), but comparable to those measured in France (Philippat
et al., 2012) and Puerto Rico (Meeker et al., 2013) (Supplemental
Fig. S3). It is unknownwhether differences in laboratorymethodsmay ac-
count for the disparities observed; however, multiple urine samples per
womanwere collected in our P4 Studywhilemost of the other studies, in-
cluding the other Canadian study collected only one urine sample, there-
by reducing the impact of intra-individual variability over time.
A recent Chinese study reported mean total triclosan in urine of
infants ≤6 months of age of 4.04 ng/mL (LOD 0.13) (Liu et al., 2014).
A study of infants in neonatal intensive care units has measured triclo-
san in infant urine and reported that 81% of the samples were below
the LOD (2.3 μg/L) with a maximum value of 16.7 μg/L (Calafat et al.,
2009). Thirty-nine percent of our infant urines were b LOD (3 μg/L)
and the maximum result was 99.9 μg/L.
Triclosan has beenmeasured in breastmilk in several countries. On a
fresh weight basis, higher maximum values were reported in our study
(median: 0.45 ng/g; range: 0–73.18 ng/g) than in Australia (median:
0.26; range: b0.019–19 ng/g) (Toms et al., 2011); however a Swedish
study reported the highest maximum value (median in “exposed”
0.54; range: b0.018–0.95 ng/g) (Allmyr et al., 2006). Our maximum
lipid-adjusted results (2287 ng/g lipids) were higher than those report-
ed in the U.S. (2100 μg/kg) (Dayan, 2007) and China (308.6 ng/g lipids)
(Wang et al., 2011).
Similar to the Flemish Health and Environment Study (Den Hond
et al., 2013), we observed very large inter-individual variability in
urinary concentrations of TCS (from none detected to 3229 μg/L). In
the Flemish Study, higher urinary TCS was associated with increased
use of personal care products but not with age, BMI, educational level,
smoking or urbanization (Den Hond et al., 2013). Higher maternal
urinary TCS concentrations have been reported in women with more
education and income (Bertelsen et al., 2014; Arbuckle et al., 2014a).
We observed no consistent signiﬁcant associations between maternal
exposure to TCS and any socio-demographic variables; however, some-
what higher TCS concentrations in women with more education and
income were noted.
Triclocarban was rarely detected in any of the biospecimens tested
in our study (4% of maternal urines), which may reﬂect limited use
of this substance in Canada as well as a less sensitive method for
measuring TCC (LOD in urine: 1.1 μg/L; whereas the CDC method
had a LOD of 0.1 ng/mL and detected TCC in 35% of urines (Zhou et al.,
2012)). An analysis of 100 urine samples in Greece for TCC (LOQ
was 0.5 ng/mL) found only 4% with detectable concentrations
(Asimakopoulos et al., 2014). In contrast, among 200 pregnant
women in Denmark, 54% had detectable concentrations of TCC in their
urine, with a LODof 0.01 μg/L (Tefre de Renzy-Martin et al., 2014); how-
ever TCC was detected in only 18% of urines from a larger group of the
Danish cohort (Frederiksen et al., 2014) and TCC was detected in 25%of ﬁrst morning voids from mothers in another study (Frederiksen
et al., 2013).4.2. BPA
In contrast to triclosan, there have been a number of studies
published which have measured urinary concentrations of total BPA
during pregnancy (Supplemental Fig. S4). Median concentrations
were at least 2.0 μg/L in studies conducted in France (Philippat et al.,
2012), Cincinnati (Braun et al., 2011b), Spain (Casas et al., 2013),
Australia (Callan et al., 2013) and Puerto Rico (Meeker et al., 2013)
and less than 1.0 μg/L in New York Mennonites (Martina et al., 2012),
Mexico (Lewis et al., 2013) and Canada (Arbuckle et al, 2014b). The
median BPA in our study (1.21 μg/L) was comparable to that of cohorts
in California (Harley et al, 2013b), New York (Wolff et al, 2008), Korea
(Lee et al., 2014), NCS pilot sites (Mortensen et al., 2014) and
Denmark (Tefre de Renzy-Martin et al, 2013; Frederiksen et al., 2014).
Differences in dietary exposures (through types and amounts of con-
taminated foods consumed), sampling protocols and to a lesser extent,
other sources of BPA exposure such as paper and paper products, in-
cluding thermal receipts (Liao and Kannan, 2011) may explain
variances in exposure between populations.
We noted that infants who were exclusively fed with formula
had signiﬁcantly higher total BPA in their urine, compared to those
who were exclusively breastfed or by a combination of both formula
and breast feeding. As BPA was not detected in 70% of the formula
and 95% of the breast milk, this suggests that the bottles may be
the main source of BPA for the infants. However, information was
not available on the frequency of feeding with bottles containing
expressed breast milk.
A few studies have measured infant exposure to BPA. Studies of
hospitalized infants (NICU) reported urinary concentrations of free
and total BPA at least one order of magnitude higher (Calafat et al.,
2009; Duty et al., 2013) than in studies of healthy infants, who generally
hadmedian free BPAbelow the limit of detection and total BPA less than
2 μg/L (Liu et al., 2014; Mendonca et al., 2014; Nachman et al., 2013),
comparable to what we observed.
Several studies have measured free and total BPA in breast milk but
at higher concentrations than those measured in our study where
approximately 95% of the samples had no detectable BPA. For example,
the median total BPA in three US studies ranged from around 0.8 μg/L
(Ye et al., 2008; Mendonca et al., 2014) to 1.3 μg/L (Duty et al., 2013),
and free BPA ranged from less than the LOD to around 0.7 μg/L (Ye
et al., 2008; Zimmers et al., 2014). While the most recent American
study (Zimmers et al., 2014) had a lower LOD (0.22 ng/mL), than
that of our study (0.3 ng/mL), this likely does not explain the higher
detection of free BPA (60%) versus 4% in our study. Another American
study (Mendonca et al., 2014) had the same LOD for free BPA as our
study but reported 20% of the milk samples had detectable free BPA.
A NewYork City cohort study has reported that geometricmeans for
maternal prenatal BPA concentrations in urine were signiﬁcantly lower
than paired children's postnatal concentrations at ages 3 to 7 years and
suggested that BPA in pregnant women may be temporarily diverted
from the excretory process due to transfer across the placenta
(Hoepner et al., 2013). However there is no evidence from our study
or that of Braun and colleagues (Braun et al., 2012) that urinary
BPA concentrations are overall lower in pregnancy than in the non-
pregnant state. Braun et al., 2011b did report median BPA decreasing
across pregnancy, while our study reported the highest concentrations
at 32–36 weeks.
While we observed that autumn collections were a signiﬁcant
predictor of BPA exposure, one study has reported BPA geometric
mean concentrations in urine samples collected in the summer months
were consistently higher than concentrations in non-summer months
(Hoepner et al., 2013). Urinary BPA concentrations have been positively
582 T.E. Arbuckle et al. / Science of the Total Environment 508 (2015) 575–584associated with water consumption from re-usable polycarbonate
bottles in summer months among females (Makris et al., 2013).
4.3. Meconium
No previous study has measured phenols in meconium. As meconi-
um begins to form in the fetus as early as the 12th week of gestation,
chemicals can accumulate in meconium through to delivery (Ostrea
et al., 2006). Meconium is therefore a cumulative repository of many
of the xenobiotics that the fetus is exposed to throughout pregnancy,
compared to an acute phase matrix such as blood or urine. Hence,
meconium may be a better matrix to measure prenatal exposure to
short-lived chemicals such as phenols. While meconium can be messy
to handle and complex to analyze, large amounts can be collected.
Unlike cord blood, there is no competition with tissue banks for this
material. We have no explanation for the observation of signiﬁcantly
higher concentrations of phenols in meconium from females than
males. The meconium results must be interpreted with caution, how-
ever, especially given that the phenols are non-persistent chemicals
frequently detected in urine. Cross-contamination of the meconium
sample with urine may have occurred which would reﬂect exposure
during gestation as well as during delivery (Calafat and Needham,
2009). The sex differences in concentrations in meconium were
not reﬂected in infant urines. This suggests that contamination of the
meconiumwith infant urinewas not an issue in this study or anatomical
differences resulted in female meconium being more contaminated
with urine than male meconium. However, our examination of phthal-
ate metabolites in meconium did not show any differences by sex
(unpublished data). The length of time that the meconium is in contact
with the diaper may also affect chemical concentrations as the ﬂuid in
the meconium may be retained by the diaper, resulting in artiﬁcially
lower concentrations. Although staff were told to record whether
there was evidence of urine in the diaper, in most cases, no information
was provided. In addition, in a few cases, the provided diaper liner was
not used. Vaseline® and Pampers® wipes were commonly used in the
hospitals; however, there is no evidence that these products contained
triclosan or BPA (US Department of Health and Human Services,
http://hpd.nlm.nih.gov/index.htm, accessed December 24, 2013).
Additionally, the meconium concentration could be affected if all the
meconium was not collected and well homogenized, as meconium
excreted ﬁrst can vary in concentration to later excretions which may
also contain postnatal stool (Zelner et al., 2012).
4.4. Potential contamination of samples
Unintended random or systematic contamination of the samples in
our study cannot be ruled out. Samples of the collection materials
were pre-screened and ﬁeld blanks were included to try to minimize
blatant sources of contamination. Our analysis showed only trace
contamination of 6% of the maternal and 3% of the breast milk ﬁeld
blanks with total BPA, which suggests that potential contamination
from the processes was minimal. BPA contamination of milk samples
has been reported from the leaching of BPA from a speciﬁc lot of
microcentrifuge tubes, even though the tubes were presented as made
of polypropylene, which is not known to contain BPA (Ye et al., 2013).
Contamination of the laboratory can also come from indoor dust
which has been found to contain BPA (Loganathan and Kannan, 2011)
and triclosan (Fan et al., 2010). The absorbent underpad used to cover
the workspace in some laboratory benches may also be a source
of BPA contamination (Ye et al., 2013). Random contamination with
triclosan has also been observed in labs where the hand soap in the
restroom dispensers contained triclosan and when one of the analysts
used triclosan containing toothpaste (Ye et al., 2013). As Ye and
colleagues noted, random contamination can be difﬁcult to identify
and trace even by experienced researchers adhering to a comprehensive
quality control protocol.5. Conclusions
Our results showed that themain predictors ofmaternal exposure to
BPA or TCS, adjusted for speciﬁc gravity were time of day, weekend and
autumn collections. Time since last void was only a predictor of mater-
nal TCS exposure. However, these results are tempered by the fact that
the sample size is small and the women are primarily from a higher
socio-demographic group than the general population. After ﬁnding
considerable within day variability for BPA, Ye et al. (2011b) suggested
that the time of day of urine collection and the time since last void be
collected when measuring this chemical. Both the timing of the sample
relative to food consumption and previous bladder voiding has a direct
impact on the estimated exposure concentrations in spot urines
(Ye et al., 2011b). We found signiﬁcantly higher concentrations of
BPA, in the evening between 4:00 pm and midnight versus during the
day or overnight; whereas TCS concentrations were signiﬁcantly higher
in the mornings and early afternoons. Therefore we recommend that
time of urine collection and time since last void be routinely collected
in biomonitoring studies.
The correlations observed between maternal urinary triclosan
with meconium, breast milk and infant urine concentrations, suggest
that maternal exposures may be the main source of exposure for
the young infant. Our small sample size limited the study's ability
to identify maternal characteristics (e.g., household income, age,
education, occupation) that were predictive of maternal urinary phenol
concentrations.
In conclusion, our study showed that the majority of pregnant
women in this highly educated population were exposed to BPA and
TCS and that their fetuses and infants are also exposed but to a lesser
extent. Data from extensive biomonitoring studies in susceptible sub-
populations such as that in the P4 Study, will add to the quality of the
risk assessment.Acknowledgments
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